1. Home
  2. BSVN vs PRTA Comparison

BSVN vs PRTA Comparison

Compare BSVN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSVN
  • PRTA
  • Stock Information
  • Founded
  • BSVN 2004
  • PRTA 2012
  • Country
  • BSVN United States
  • PRTA Ireland
  • Employees
  • BSVN N/A
  • PRTA N/A
  • Industry
  • BSVN Major Banks
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BSVN Finance
  • PRTA Health Care
  • Exchange
  • BSVN Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • BSVN 393.6M
  • PRTA 472.1M
  • IPO Year
  • BSVN 2018
  • PRTA N/A
  • Fundamental
  • Price
  • BSVN $41.22
  • PRTA $10.26
  • Analyst Decision
  • BSVN Buy
  • PRTA Buy
  • Analyst Count
  • BSVN 3
  • PRTA 9
  • Target Price
  • BSVN $53.33
  • PRTA $16.14
  • AVG Volume (30 Days)
  • BSVN 14.7K
  • PRTA 562.9K
  • Earning Date
  • BSVN 10-15-2025
  • PRTA 11-06-2025
  • Dividend Yield
  • BSVN 2.31%
  • PRTA N/A
  • EPS Growth
  • BSVN 19.43
  • PRTA N/A
  • EPS
  • BSVN 4.54
  • PRTA N/A
  • Revenue
  • BSVN $95,710,000.00
  • PRTA $10,341,000.00
  • Revenue This Year
  • BSVN N/A
  • PRTA N/A
  • Revenue Next Year
  • BSVN $2.23
  • PRTA $602.32
  • P/E Ratio
  • BSVN $9.16
  • PRTA N/A
  • Revenue Growth
  • BSVN 11.45
  • PRTA N/A
  • 52 Week Low
  • BSVN $32.49
  • PRTA $4.32
  • 52 Week High
  • BSVN $50.26
  • PRTA $18.78
  • Technical
  • Relative Strength Index (RSI)
  • BSVN 30.72
  • PRTA 54.06
  • Support Level
  • BSVN $40.57
  • PRTA $10.34
  • Resistance Level
  • BSVN $42.10
  • PRTA $11.17
  • Average True Range (ATR)
  • BSVN 0.88
  • PRTA 0.56
  • MACD
  • BSVN -0.09
  • PRTA -0.04
  • Stochastic Oscillator
  • BSVN 17.97
  • PRTA 31.25

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: